Rapport Therapeutics (RAPP) Research & Development (2023 - 2026)
Rapport Therapeutics (RAPP) recorded Research & Development of $51.41 million in Q2 2026, up 126.7% from $22.68 million a year earlier and up 57.2% from the prior quarter.
Powered by 
Analysis
Rapport Therapeutics (RAPP) Research & Development (2023 - 2026) Analysis & Trends
On a TTM basis, Rapport Therapeutics' Research & Development came in at $136.67 million as of Jun 30, 2026, up 82.2% year-over-year; for FY2025, it came in at $94.79 million, up 55.6% from FY2024.
- Across earlier years, Research & Development came in at $60.94 million in FY2024 (+117.6%) and $28 million in FY2023.
- The Q2 2026 figure is the highest quarterly Research & Development in data going back to Q2 2023.
- On a year-over-year basis, Research & Development has increased for nine consecutive quarters, with growth averaging 70.6% over the last eight quarters.
- The year-over-year growth in Research & Development has ranged between 43.3% (Q3 2025) and 232.3% (Q2 2024) over the last five years.
- Per Business Quant, the preceding three quarters came in at $32.72 million (Q1 2026), $30.26 million (Q4 2025) and $22.28 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.22 Bn | 1,098.81 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 613.62 Bn | 532.15 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 501.46 Bn | 474.57 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 366.84 Bn | 321.22 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 297.85 Bn | 261.84 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 235.39 Bn | 190.79 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 190.66 Bn | 164.86 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 169.57 Bn | 116.22 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Rapport Therapeutics | 1.27 Bn | 448.61 Mn | - | 51.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 51.41 Mn |
| Mar 31, 2026 | 32.72 Mn |
| Dec 31, 2025 | 30.26 Mn |
| Sep 30, 2025 | 22.28 Mn |
| Jun 30, 2025 | 22.68 Mn |
| Mar 31, 2025 | 19.57 Mn |
| Dec 31, 2024 | 17.20 Mn |
| Sep 30, 2024 | 15.54 Mn |
| Jun 30, 2024 | 15.69 Mn |
| Mar 31, 2024 | 12.50 Mn |
| Dec 31, 2023 | 11.80 Mn |
| Sep 30, 2023 | 7.58 Mn |
| Jun 30, 2023 | 4.72 Mn |
API Access
Rapport Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=RAPP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "RAPP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=RAPP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();